LAVA Therapeutics N.V.
Price Action
Technical Summary
WEAKENINGLAVA Therapeutics N.V. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 73), indicating performance broadly in line with the market. Earnings growth of 41% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.68 | +3.57% | ABOVE |
| 50 SMA | $1.61 | +7.89% | ABOVE |
| 100 SMA | $— | — | |
| 150 SMA | $— | — | |
| 200 SMA | $1.41 | +23.37% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is LVTX in an uptrend right now?
LVTX has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is LVTX overbought or oversold?
LVTX's RSI (14) is 63. The stock is in neutral territory, neither overbought nor oversold.
Is LVTX outperforming the market?
LVTX has a Relative Strength (RS) Rating of 73 out of 99. LVTX is performing about average compared to the market.
Where is LVTX in its 52-week range?
LVTX is trading at $1.74, which is 95% of its 52-week high ($1.83) and 83% above its 52-week low ($1.29).
How volatile is LVTX?
LVTX has a Beta of -0.15 and 52-week volatility of 39%. It's less volatile than the S&P 500 - generally more stable.